Article Text

Download PDFPDF
Effects of popliteal plexus block after total knee arthroplasty: a randomized clinical trial
  1. Johan Kløvgaard Sørensen1,2,
  2. Ulrik Grevstad3,
  3. Pia Jaeger4,
  4. Lone Nikolajsen1,5 and
  5. Charlotte Runge1,2
  1. 1Department of Clinical Medicine, Aarhus University, Aarhus, Denmark
  2. 2Elective Surgery Centre, Silkeborg Regional Hospital, Silkeborg, Denmark
  3. 3Department of Anesthesiology, Gentofte Hospital, Hellerup, Hovedstaden, Denmark
  4. 4The Juliane Marie Centre, Rigshospitalet, Copenhagen, Denmark
  5. 5Department of Anaesthesiology, Aarhus University Hospital, Aarhus, Denmark
  1. Correspondence to Dr Johan Kløvgaard Sørensen, Department of Clinical Medicine, Aarhus University, Aarhus N, Denmark; jklovgaard{at}gmail.com

Abstract

Background and objectives Motor-sparing peripheral nerve blocks enhance multimodal opioid-sparing strategies after total knee arthroplasty. We hypothesized that adding a popliteal plexus block to a femoral triangle block could reduce 24-hour opioid consumption after total knee arthroplasty, compared with standalone femoral triangle block or adductor canal block.

Methods This patient- and assessor-blinded, randomized controlled trial allocated 165 patients into three equally sized parallel groups, receiving either 1) popliteal plexus block+femoral triangle block, 2) femoral triangle block, or 3) adductor canal block. Intravenous oxycodone was administered via patient-controlled analgesia pumps. The primary outcome was 24-hour postoperative opioid consumption. Secondary outcomes were preoperative maximum voluntary isometric contraction and manual muscle tests of knee and ankle movement assessed before and after the nerve block procedure together with postoperative pain scores, mobilization, and 12-hour opioid consumption.

Results 24-hour postoperative intravenous oxycodone consumption varied significantly between groups (p<0.01), with medians (IQR) of 6 mg (2–12) in the popliteal plexus block+femoral triangle block group, 10 mg (8–16) in the femoral triangle block group, and 12 mg (6–18) in the adductor canal block group. Median consumption in the popliteal plexus block+femoral triangle block group was reduced by −4 mg (95% CI −7.4 to –1.0, p<0.01) and −6 mg (95% CI −8.3 to –1.3, p=0.01) compared with groups of femoral triangle block and adductor canal block, respectively. No differences were found in pain scores, mobilization, or changes in preoperative muscle strength. Post hoc analysis revealed successful 24-hour opioid-free postoperative care among 12 patients with popliteal plexus block+femoral triangle block, as compared with two with femoral triangle block and six with adductor canal block.

Conclusion Adding a popliteal plexus block to a femoral triangle block resulted in a statistically significant reduction of 24-hour postoperative opioid consumption after total knee arthroplasty. However, no differences were found in pain scores. Popliteal plexus block did not impair the lower leg muscles.

  • lower extremity
  • pain, postoperative
  • analgesics, opioid
  • nerve block

Data availability statement

Data are available upon reasonable request.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Data availability statement

Data are available upon reasonable request.

View Full Text

Footnotes

  • Contributors Devised protocol: all authors. Made draft for this paper: JKS. Revised and approved draft for this paper: all authors. Approved final manuscript: all authors. The principal investigator and guarantor was JKS. Sponsor was CR. Since I am not a native English writer, I have used the AI program Grammarly only for correcting language, spelling, and syntax in the presented article.

  • Funding The principal investigator and PhD student JKS received partial salary funding from the Danish Rheumatism Association (a grant of 250 000 DKK) and Aarhus University, Denmark (a PhD grant of 1 250 000 DKK). The funders did not influence the trial protocol, trial conduct, or results reporting.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.